|
1
|
Truman JP, Choqueux C, Charron D and
Mooney N: HLA class II molecule signal transduction leads to either
apoptosis or activation via two different pathways. Cell Immunol.
172:149–157. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ford SA and Blanck G: Signal persistence
and amplification in cancer development and possible, related
opportunities for novel therapies. Biochim Biophys Acta.
1855:18–23. 2015.PubMed/NCBI
|
|
3
|
Macián F, Im SH, García-Cózar FJ and Rao
A: T-cell anergy. Curr Opin Immunol. 16:209–216. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Szekeres K, Koul R, Mauro J, Lloyd M,
Johnson J and Blanck G: An Oct-1-based, feed-forward mechanism of
apoptosis inhibited by co-culture with Raji B-cells: Towards a
model of the cancer cell/B-cell microenvironment. Exp Mol Pathol.
97:585–589. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Field SJ, Tsai FY, Kuo F, Zubiaga AM,
Kaelin WG Jr, Livingston DM, Orkin SH and Greenberg ME: E2F-1
functions in mice to promote apoptosis and suppress proliferation.
Cell. 85:549–561. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu X and Levine AJ: p53 and E2F-1
cooperate to mediate apoptosis. Proc Natl Acad Sci USA.
91:3602–3606. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yamasaki L, Jacks T, Bronson R, Goillot E,
Harlow E and Dyson NJ: Tumor induction and tissue atrophy in mice
lacking E2F-1. Cell. 85:537–548. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Oswald F, Dobner T and Lipp M: The E2F
transcription factor activates a replication-dependent human H2A
gene in early S phase of the cell cycle. Mol Cell Biol.
16:1889–1895. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Banerjee D, Ercikan-Abali E, Waltham M,
Schnieders B, Hochhauser D, Li WW, Fan J, Gorlick R, Goker E and
Bertino JR: Molecular mechanisms of resistance to antifolates, a
review. Acta Biochim Pol. 42:457–464. 1995.PubMed/NCBI
|
|
10
|
Berry DE, Lu Y, Schmidt B, Fallon PG,
O'Connell C, Hu SX, Xu HJ and Blanck G: Retinoblastoma protein
inhibits IFN-gamma induced apoptosis. Oncogene. 12:1809–1819.
1996.PubMed/NCBI
|
|
11
|
McKay BC, Becerril C, Spronck JC and
Ljungman M: Ultraviolet light-induced apoptosis is associated with
S-phase in primary human fibroblasts. DNA Repair (Amst). 1:811–820.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mauro JA and Blanck G: Functionally
distinct gene classes as bigger or smaller transcription factor
traps: A possible stochastic component to sequential gene
expression programs in cancer. Gene. 536:398–406. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Garcia M, Mauro JA, Ramsamooj M and Blanck
G: Tumor suppressor genes are larger than apoptosis-effector genes
and have more regions of active chromatin: Connection to a
stochastic paradigm for sequential gene expression programs. Cell
Cycle. 14:2494–2500. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lu H, Liang X, Issaenko OA and Hallstrom
TC: Jab1/CSN5 mediates E2F dependent expression of mitotic and
apoptotic but not DNA replication targets. Cell Cycle.
10:3317–3326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu H and Hallstrom TC: The nuclear protein
UHRF2 is a direct target of the transcription factor E2F1 in the
induction of apoptosis. J Biol Chem. 288:23833–4333. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Teitz T, Wei T, Valentine MB, Vanin EF,
Grenet J, Valentine VA, Behm FG, Look AT, Lahti JM and Kidd VJ:
Caspase 8 is deleted or silenced preferentially in childhood
neuroblastomas with amplification of MYCN. Nat Med. 6:529–535.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yavorski JM and Blanck G: TCGA: Increased
oncoprotein coding region mutations correlate with a greater
expression of apoptosis-effector genes and a positive outcome for
stomach adenocarcinoma. Cell Cycle. 15:1–7. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mauro JA, Butler SN, Ramsamooj M and
Blanck G: Copy number loss or silencing of apoptosis-effector genes
in cancer. Gene. 554:50–57. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mauro JA, Yavorski JM and Blanck G:
Stratifying melanoma and breast cancer TCGA datasets on the basis
of the CNV of transcription factor binding sites common to
proliferation- and apoptosis-effector genes. Gene. 614:37–48. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Callahan BM, Patel JS, Fawcett TJ and
Blanck G: Cytoskeleton and ECM tumor mutant peptides: Increased
protease sensitivities and potential consequences for the HLA class
I, mutant epitope reservoir. Int J Cancer. 142:988–998. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yavorski JM and Blanck G: Smoking
correlates with increased cytoskeletal protein-related coding
region mutations in the lung and head and neck datasets of the
cancer genome atlas. Physiol Rep. 4:pii: e13045. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sikaria D, Tu YN, Fisler DA, Mauro JA and
Blanck G: Identification of specific feed-forward apoptosis
mechanisms and associated higher survival rates for low grade
glioma and lung squamous cell carcinoma. J Cancer Res Clin Oncol.
144:459–468. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lieberman J: Granzyme A activates another
way to die. Immunol Rev. 235:93–104. 2010. View Article : Google Scholar : PubMed/NCBI
|
